相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
Paolo Verdecchia et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
Muthiah Vaduganathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Does Ibuprofen Worsen COVID-19?
Nicholas Moore et al.
DRUG SAFETY (2020)
Functional Complexes of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Receptors: Expression in Adult but Not Fetal Lung Tissue
Rafael Franco et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Clinical Relevance and Role of Neuronal AT1 Receptors in ADAM17-Mediated ACE2 Shedding in Neurogenic Hypertension
Jiaxi Xu et al.
CIRCULATION RESEARCH (2017)
Angiotensin II Mediates Angiotensin Converting Enzyme Type 2 Internalization and Degradation Through an Angiotensin II Type I Receptor-Dependent Mechanism
Matthew R. Deshotels et al.
HYPERTENSION (2014)
EP2 signaling mediates suppressive effects of celecoxib on androgen receptor expression and cell proliferation in prostate cancer
E. Kashiwagi et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2014)
TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds
Shiori Haga et al.
ANTIVIRAL RESEARCH (2010)
Cyclooxygenase-2 inhibitors attenuate angiotensin II-induced oxidative stress, hypertension, and cardiac hypertrophy in rats
R Wu et al.
HYPERTENSION (2005)
分享论文
